CURRENT APPROACHES TO TREATING NON-RHABDOID SOFT TISSUE SARCOMAS OF THE HEAD AND NECK IN CHILDREN: A REVIEW OF LITERATURE
https://doi.org/10.17650/2222-1468-2012-0-2-92-96
Abstract
Soft tissue sarcomas constitute approximately 8–10 % of all malignancies in children and adolescents and half of them are rhabdomyosarcoma. The second half makes up a heterogeneous group of malignancies of mesenchymal non-rhabdoid origin, which have been recently referred to as an individual group of non-rhabdoid soft tissue sarcomas (an adult type) in increasing frequency. The choice of a treatment option depends on a number of factors: its histological structure, location, stage of a tumor; the possible performance of radical surgery; and the grade of tumor differentiation. Surgery is the basic treatment; if it is impossible, chemoradiotherapy is performed at stage 1.
About the Authors
M. V. Bolotin
Russian Children’s Clinical Hospital, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
A. V. Lopatin
Russian Children’s Clinical Hospital, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Ferrari A., Casanova M. Specification on the definition of adult-type soft tissue sarcoma. J Clin Oncol 2006;24(24):4042−3.
2. Grovas A., Fremgen A., Rauck A. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997;80:2321−32.
3. Gurney J.G., Smith M.A., Ross J.A. SEER Cancer incidence and survival among children and adolescents: United States SEER Program 1975−1995. National Institutes of Health: 99-4649.
4. Cancer Epidemiology in Older Adolescents and Young Adults 1975−2000. National Institutes of Health: 06-5767.
5. Rao B.N. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin Surg Oncol 1993;9(6):524−31.
6. Spunt S.L., Poquette C.A., Hurt Y.S. et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol 1999; 17(12):3697−705.
7. Andrassy R.J. Advances in the surgical management of sarcomas in children. Am J Surg 2002;184(6):484−91.
8. Hayes-Jordan A.A., Spunt S.L., Poquette C.A. et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J Pediatr Surg 2000; 35(6):948−54.
9. Ferrari A., Casanova M., Collini P. et al. Adult-type soft tissue sarcomas in pediatricage patients: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005 June 20; 23(18):4021−30.
10. Rao B.N., Etcubanas E.E., Green A.A. Present-day concepts in the management of sarcomas in children. Cancer Invest 1989; 7(4):349−56.
11. Dillon P.W., Maurer H., Jenkins J. et al. A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. J Pediatr Surg 1992;27:241−5.
12. Pappo A.S., Rao B.N., Jenkins J. et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children’s Research Hospital experience. Med Pediatr Oncol 1999; 33(2):76−82.
13. Rao B.N. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin Surg Oncol 1993; 9(6):524−31.
14. Andrassy R.J. Advances in the surgical management of sarcomas in children. Am J Surg 2002;184(6):484−91.
15. Paulino A.C., Ritchie J., Wen B.C. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer 2004; 43:587−93.
16. Mark R.J., Poen J., Tran L.M. et al. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 1994; 73(10):2653−62.
17. Kuttesch J.F. Jr, Wexler L.H., Marcus R.B. et al. Second malignancies after Ewing’s sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996; 14(10):2818−25.
18. Hawkins M.M. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys 1990 Nov; 19(5):1297−301.
19. Meadows A.T. Second malignant neoplasms in childhood cancer survivors. J Assoc Pediatr Oncol Nurses 1989; 6(1):7−11.
20. Pratt C.B., Pappo A.S., Gieser P. et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol 1999;17(4):1219−26.
21. Yang J.C., Chang A.E., Baker A.R. et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197−203.
22. Ferrari A. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft tissue sarcomas. Expert Rev Anticancer Ther 2008; 8(6);929−38.
23. Pappo A.S., Devidas M., Jenkins J. et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advancedstage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol 2005;23(18): 4031−7.
24. Nathan P.C., Tsokos M., Long L. et al. Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer 2005; 44(5):449−54.
25. Daw N.C., Billups C.A., Pappo A.S. et al. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children’s Research Hospital experience. Cancer 2003;97(11): 2839−47.
26. Wan X., Helman L.J. The biology behind mTOR inhibition in sarcoma. Oncologist 2007;12:1007−18.
27. Heymach J.V. Angiogenesis and antiangiogenic approaches to sarcomas. Curr Opin Oncol 2001;12:261−9.
Review
For citations:
Bolotin M.V., Lopatin A.V. CURRENT APPROACHES TO TREATING NON-RHABDOID SOFT TISSUE SARCOMAS OF THE HEAD AND NECK IN CHILDREN: A REVIEW OF LITERATURE. Head and Neck Tumors (HNT). 2012;(2):92-96. (In Russ.) https://doi.org/10.17650/2222-1468-2012-0-2-92-96
Views:
697
Email this article 